AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Big Data Mining and Analytics Article
PDF (1.6 MB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Open Access

Analysis of Protein-Ligand Interactions of SARS-CoV-2 Against Selective Drug Using Deep Neural Networks

St. Peter’s Institute of Higher Education and Research, Chennai 600054, India
Information Communication Technology Academy, Chennai 600096, India
Department of Computer Science and Engineering, SNS College of Engineering, Coimbatore 641107, India
Department of Computer Science and Engineering, Jagannath Educational Health and Charitable Trust College of Engineering and Technology, Coimbatore 641105, India
B. S. Abdur Rahman Crescent Institute of Science and Technology, Chennai 600048, India
Department of Computer Science, Government Bikram College of Commerce, Patiala 147001, India
Department of Computer Science and Engineering, Sri Guru Granth Sahib World University, Fatehgarh 140406, India
Show Author Information

Abstract

In recent time, data analysis using machine learning accelerates optimized solutions on clinical healthcare systems. The machine learning methods greatly offer an efficient prediction ability in diagnosis system alternative with the clinicians. Most of the systems operate on the extracted features from the patients and most of the predicted cases are accurate. However, in recent time, the prevalence of COVID-19 has emerged the global healthcare industry to find a new drug that suppresses the pandemic outbreak. In this paper, we design a Deep Neural Network (DNN) model that accurately finds the protein-ligand interactions with the drug used. The DNN senses the response of protein-ligand interactions for a specific drug and identifies which drug makes the interaction that combats effectively the virus. With limited genome sequence of Indian patients submitted to the GISAID database, we find that the DNN system is effective in identifying the protein-ligand interactions for a specific drug.

Keywords

deep learningDeep Neural Network (DNN)coronavirusprotein-ligand interactionsclinical healthcare system

References

[1]
A. K. Singh, A. Singh, A. Shaikh, R. Singh, and A. Misra, Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries, Diabetes Metab. Syndr. Clin. Res. Rev., vol. 14, no. 3, pp. 241-246, 2020.
Crossref Google Scholar
[2]
J. Y. Yang, A. Roy, and Y. Zhang, Protein-ligand binding site recognition using complementary binding-specific substructure comparison and sequence profile alignment, Bioinformatics, vol. 29, no. 20, pp. 2588-2595, 2013.
Crossref Google Scholar
[3]
Y. F. Cui, Q. W. Dong, D. C. Hong, and X. Wang, Predicting protein-ligand binding residues with deep convolutional neural networks, BMC Bioinformatics, vol. 20, no. 1, p. 93, 2019.
Crossref Google Scholar
[4]
S. Wang, S. Q. Sun, Z. Li, R. Y. Zhang, and J. B. Xu, Accurate de novo prediction of protein contact map by ultra-deep learning model, PLoS Comput. Biol., vol. 13, no. 1, p. e1005324, 2017.
Crossref Google Scholar
[5]
J. Y. Yang, A. Ro, and Y. Zhang, BioLiP: A semi-manually curated database for biologically relevant ligand-protein interactions, Nucl. Acids Res., vol. 41, no. D1, pp. D1096-D1103, 2012.
Crossref Google Scholar
[6]
D. Mothay and K. V. Ramesh, Binding site analysis of potential protease inhibitors of COVID-19 using AutoDock, VirusDis., vol. 31, no. 2, pp. 194-199, 2020.
Crossref Google Scholar
[7]
L. Huang, R. Han, T. Ai, P. X. Yu, H. Kang, Q. Tao, and L. M. Xia, Serial quantitative chest CT assessment of COVID-19: Deep-learning approach, Radiol. Cardiothorac. Imaging, vol. 2, no. 2, p. e200075, 2020.
Crossref Google Scholar
[8]
L. Li, L. X. Qin, Z. G. Xu, Y. B. Yin, X. Wang, B. Kong, J. J Bai, Y. Lu, Z. H. Fang, Q. Song, et al., Artificial intelligence distinguishes COVID-19 from community acquired pneumonia on chest CT, , 2020.
Crossref
[9]
I. D. Apostolopoulos and T. A. Mpesiana, Covid-19: Automatic detection from X-ray images utilizing transfer learning with convolutional neural networks, Phys. Eng. Sci. Med., vol. 431, pp. 635-640, 2020.
Crossref Google Scholar
[10]
C. Butt, J. Gill, D. Chun, and B. A. Babu, Deep learning system to screen coronavirus disease 2019 pneumonia, Appl. Intell., .
Crossref Google Scholar
[11]
C. S. Zheng, X. B. Deng, Q. Fu, Q. Zhou, J. P. Feng, H. Ma, W. Y. Liu, and X. G. Wang, Deep learning-based detection for COVID-19 from chest CT using weak label, , 2020.
Crossref
[12]
D. S. Li, D. W. Wang, J. P. Dong, N. N. Wang, H. Huang, H. W. Xu, and C. Xia, False-negative results of real-time reverse-transcriptase polymerase chain reaction for severe acute respiratory syndrome coronavirus 2: Role of deep-learning-based CT diagnosis and insights from two cases, Korean J. Radiol., vol. 21, no. 4, pp. 505-508, 2020.
Crossref Google Scholar
[13]
H. P. Zhang, K. M. Saravanan, Y. Yang, M. T. Hossain, J. X. Li, X. H. Ren, Y. Pan, and Y. J. Wei, Deep learning based drug screening for novel coronavirus 2019-nCov, Interdiscip. Sci. Comput. Life Sci., .
Crossref Google Scholar
[14]
M. Torrisi, G. Pollastri, and Q. Le, Deep learning methods in protein structure prediction, Comput. Structural Biotechnol. J., vol. 18, pp. 1301-1310, 2020.
Crossref Google Scholar
[15]
D. E. Rumelhart, G. E. Hinton, and R. J. Williams, Learning representations by back-propagating errors, Nature, vol. 323, no. 6088, pp. 533-536, 1986.
Crossref Google Scholar
[16]
A. W. Senior, R. Evans, J. Jumper, J. Kirkpatrick, L. Sifre, T. Green, C. L. Qin, A. Žídek, A. W. R. Nelson, A. Bridgland, et al., Improved protein structure prediction using potentials from deep learning, Nature, vol. 577, no. 7792, pp. 706-710, 2020.
Crossref Google Scholar
[17]
J. L. Elman, Finding structure in time, Cogn. Sci., vol. 14, no. 2, pp. 179-211, 1990.
Crossref Google Scholar
[18]
S. Wang, J. Peng, J. Z. Ma, and J. B. Xu, Protein secondary structure prediction using deep convolutional neural fields, Sci. Rep., vol. 6, no. 1, p. 18 962, 2016.
Crossref Google Scholar
[19]
Y. LeCun, Y. Bengio, and G. Hinton, Deep learning, Nature, vol. 521, no. 7553, pp. 436-444, 2015.
Crossref Google Scholar
[20]
H. J. Hinz, Thermodynamics of protein-ligand interactions: Calorimetric approaches, Annu. Rev. Biophys. Bioeng., vol. 12, no. 1, pp. 285-317, 1983.
Crossref Google Scholar
[21]
T. Simonson, G. Archontis, and M. Karplus, Free energy simulations come of age: Protein-ligand recognition, Acc. Chem. Res., vol. 35, no. 6, pp. 430-437, 2002.
Crossref Google Scholar
[22]
R. Perozzo, G. Folkers, and L. Scapozza, Thermodynamics of protein-ligand interactions: History, presence, and future aspects, J. Recept. Signal Transduct. Res., vol. 24, nos. 1&†2, pp. 1-52, 2004.
Crossref Google Scholar
[23]
M. Hendlich, A. Bergner, J. Günther, and G. Klebe, Relibase: Design and development of a database for comprehensive analysis of protein-ligand interactions, J. Mol. Biol., vol. 326, no. 2, pp. 607-620, 2003.
Crossref Google Scholar
[24]
L. Y. Lian, I. L. Barsukov, M. J. Sutcliffe, K. H. Sze, and G. C. Roberts, Protein-ligand interactions: Exchange processes and determination of ligand conformation and protein-ligand contacts, Meth. Enzymol., vol. 239, pp. 657-700, 1994.
Crossref Google Scholar
[25]
G. Mirceva and A. Kulakov, Improvement of protein binding sites prediction by selecting amino acid residues’ features, J. Struct. Biol., vol. 189, no. 1, pp. 9-19, 2015.
Crossref Google Scholar
[26]
C. H. Yan and Y. F. Wang, A graph kernel method for DNA-binding site prediction, BMC Syst. Biol., vol. 8, no. S4, p. S10, 2014.
Crossref Google Scholar
[27]
S. C. Izidoro, R. C. de Melo-Minardi, and G. L. Pappa, GASS: Identifying enzyme active sites with genetic algorithms, Bioinformatics, vol. 31, no. 6, pp. 864-870, 2015.
Crossref Google Scholar
[28]
B. Park, J. Im, N. Tuvshinjargal, W. Lee, and K. Han, Sequence-based prediction of protein-binding sites in DNA: Comparative study of two SVM models, Comp. Methods Programs Biomed., vol. 117, no. 2, pp. 158-167, 2014.
Crossref Google Scholar
[29]
G. J. Bartlett, C. T. Porter, N. Borkakoti, and J. M. Thornton, Analysis of catalytic residues in enzyme active sites, J. Mol. Biol., vol. 324, no. 1, pp. 105-121, 2002.
Crossref Google Scholar
[30]
M. J. J. M. Zvelebil and M. J. E. Sternberg, Analysis and prediction of the location of catalytic residues in enzymes, Protein Eng. Des. Sel., vol. 2, no. 2, pp. 127-138, 1988.
Crossref Google Scholar
[31]
C. Taroni, S. Jones, and J. M. Thornton, Analysis and prediction of carbohydrate binding sites, Protein Eng. Des. Sel., vol. 13, no. 2, pp. 89-98, 2000.
Crossref Google Scholar
[32]
M. AlQuraishi, ProteinNet: A standardized data set for machine learning of protein structure, BMC Bioinform., vol. 20, no. 1, p. 311, 2019.
Crossref Google Scholar
Big Data Mining and Analytics
Volume 4 Issue 2,
June 2021
Pages 76-83
DOI: 10.26599/BDMA.2020.9020007
Cite this article:
Yuvaraj N, Srihari K, Chandragandhi S, et al. Analysis of Protein-Ligand Interactions of SARS-CoV-2 Against Selective Drug Using Deep Neural Networks. Big Data Mining and Analytics, 2021, 4(2): 76-83. https://doi.org/10.26599/BDMA.2020.9020007

1041

Views

90

Downloads

33

Crossref

27

Web of Science

40

Scopus

0

CSCD

Altmetrics
Received: 04 June 2020
Accepted: 18 June 2020
Published: 12 January 2021
© The author(s) 2021

The articles published in this open access journal are distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/).
Return